BACKGROUND: Sex hormones exhibit predictable changes in their physiologic patterns during critical illness. Endogenous estrogens are elevated in both genders as a result of the peripheral conversion of androgens to estrogens by the aromatase enzyme. Elevated endogenous estrogens have been associated with death in medical and mixed surgical intensive care unit (ICU) patients. Our objective was to determine the relationship between endogenous estrogens and outcomes in critically injured patients. METHODS: A prospective cohort of injured patients remaining in the ICU for at least 48 hours at two trauma centers was enrolled. Sex hormones (estradiol, progesterone, testosterone, prolactin, and dehydroepiandrosterone-sulfate) were assayed and mortality was assessed. A logistic regression model was used to determine the association between estradiol and death. The area under the receiver operating characteristic (AUROC) curve was used to estimate the accuracy of estradiol in predicting death. RESULTS: Nine hundred ninety-one patients were enrolled with a 13.4% mortality rate. Despite no detectable difference in mortality among genders, estradiol was significantly elevated in nonsurvivors (16 pg/mL vs. 35 pg/mL, p < 0.001). Estradiol was a marker for injury severity with the most severely injured patients exhibiting the highest levels. The ability of estradiol to predict death (AUROC = 0.65) was comparable with Trauma and Injury Severity Score (AUROC = 0.65) and superior to Injury Severity Score (AUROC = 0.54) in this cohort. CONCLUSIONS: Serum estradiol is a marker of injury severity and a predictor of death in the critically injured patient, regardless of gender. Whether or not estradiol plays a causal role in outcomes is unclear, but estrogen modulation represents a potential therapy for improving outcomes in critically ill trauma patients.
BACKGROUND: Sex hormones exhibit predictable changes in their physiologic patterns during critical illness. Endogenous estrogens are elevated in both genders as a result of the peripheral conversion of androgens to estrogens by the aromatase enzyme. Elevated endogenous estrogens have been associated with death in medical and mixed surgical intensive care unit (ICU) patients. Our objective was to determine the relationship between endogenous estrogens and outcomes in critically injured patients. METHODS: A prospective cohort of injured patients remaining in the ICU for at least 48 hours at two trauma centers was enrolled. Sex hormones (estradiol, progesterone, testosterone, prolactin, and dehydroepiandrosterone-sulfate) were assayed and mortality was assessed. A logistic regression model was used to determine the association between estradiol and death. The area under the receiver operating characteristic (AUROC) curve was used to estimate the accuracy of estradiol in predicting death. RESULTS: Nine hundred ninety-one patients were enrolled with a 13.4% mortality rate. Despite no detectable difference in mortality among genders, estradiol was significantly elevated in nonsurvivors (16 pg/mL vs. 35 pg/mL, p < 0.001). Estradiol was a marker for injury severity with the most severely injured patients exhibiting the highest levels. The ability of estradiol to predict death (AUROC = 0.65) was comparable with Trauma and Injury Severity Score (AUROC = 0.65) and superior to Injury Severity Score (AUROC = 0.54) in this cohort. CONCLUSIONS: Serum estradiol is a marker of injury severity and a predictor of death in the critically injured patient, regardless of gender. Whether or not estradiol plays a causal role in outcomes is unclear, but estrogen modulation represents a potential therapy for improving outcomes in critically ill traumapatients.
Authors: Markus W Knöferl; Martin K Angele; Michael D Diodato; Martin G Schwacha; Alfred Ayala; William G Cioffi; Kirby I Bland; Irshad H Chaudry Journal: Ann Surg Date: 2002-01 Impact factor: 12.969
Authors: Christopher J Gannon; Michael Pasquale; J Kathleen Tracy; Robert J McCarter; Lena M Napolitano Journal: Shock Date: 2004-05 Impact factor: 3.454
Authors: Andreas Valentin; Barbara Jordan; Thomas Lang; Michael Hiesmayr; Philipp G H Metnitz Journal: Crit Care Med Date: 2003-07 Impact factor: 7.598
Authors: Celestino González; Ana Alonso; Natalia A Grueso; Fernando Díaz; Manuel M Esteban; Serafina Fernández; Angeles M Patterson Journal: Steroids Date: 2002-12 Impact factor: 2.668
Authors: Julie A Garringer; Christian Niyonkuru; Emily H McCullough; Tammy Loucks; C Edward Dixon; Yvette P Conley; Sarah Berga; Amy K Wagner Journal: J Neurotrauma Date: 2013-08-15 Impact factor: 5.269
Authors: Amy K Wagner; Emily H McCullough; Christian Niyonkuru; Haishin Ozawa; Tammy L Loucks; Julie A Dobos; Christopher A Brett; Martina Santarsieri; C Edward Dixon; Sarah L Berga; Anthony Fabio Journal: J Neurotrauma Date: 2011-06-01 Impact factor: 5.269
Authors: Milap V Rakholia; Raj G Kumar; Byung-Mo Oh; Prerna R Ranganathan; Sarah L Berga; Patrick M Kochanek; Amy K Wagner Journal: J Neurotrauma Date: 2018-08-24 Impact factor: 5.269
Authors: John Tapper; Stefan Arver; Torbjörn Holm; Matteo Bottai; Mikael Machado; Ravi Jasuja; Anna Martling; Christian Buchli Journal: Eur J Surg Oncol Date: 2019-07-19 Impact factor: 4.424
Authors: Maria-Cecilia Lopez; Philip A Efron; Tezcan Ozrazgat-Baslanti; Jianyi Zhang; Joseph Cuschieri; Ronald V Maier; Joseph P Minei; Henry V Baker; Frederick A Moore; Lyle L Moldawer; Scott C Brakenridge Journal: J Trauma Acute Care Surg Date: 2016-09 Impact factor: 3.313
Authors: Joshua B Brown; Mitchell J Cohen; Joseph P Minei; Ronald V Maier; Michael A West; Timothy R Billiar; Andrew B Peitzman; Ernest E Moore; Joseph Cuschieri; Jason L Sperry Journal: J Trauma Acute Care Surg Date: 2012-12 Impact factor: 3.313
Authors: Christopher A Guidry; Brian R Swenson; Stephen W Davies; Lesly A Dossett; Kimberley A Popovsky; Hugo Bonatti; Heather L Evans; Rosemarie Metzger; Traci L Hedrick; Carlos A Tache-Léon; Tjasa Hranjec; Irshad H Chaudry; Timothy L Pruett; Addison K May; Robert G Sawyer Journal: Crit Care Med Date: 2014-05 Impact factor: 7.598